30 March 2026
Swissmedic: Mandatory Registration for Products under the Medical Devices Ordinance from July 2026
From 1 July 2026, registration of medical devices, systems, and treatment units in swissdamed under the Medical Devices Ordinance (MedDO) will become mandatory, replacing the previous notification requirement. A transition period applies until 31 December 2026. Notification obligations will continue to apply for custom-made devices, repackaged or relabelled devices, and in-house manufactured devices. From 1 January 2027, all products must be individually notified, except for custom-made devices.
For more information, see here.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Swissmedic: Haemovigilance Annual Report 2025
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
European Medicines Agency: Highlights of the September 2026 Management Board meeting